Literature DB >> 23242076

Undertreatment of pain in the prehospital setting: a comparison between trauma patients and patients with chest pain.

Karin E Bakkelund1, Erlend Sundland, Siv Moen, Gunnar Vangberg, Sindre Mellesmo, Pål Klepstad.   

Abstract

The aim of this study was to evaluate pain treatment with morphine administered by emergency medical service personnel (EMSP) to patients with chest pain and patients with pain in extremities because of trauma. This is a retrospective chart review of 2021 patients with chest pain and 887 patients with trauma. Pain was assessed using a 0-10 Numerical Rating Scale, and measured at the beginning and at the end of the ambulance care period. Trauma patients experienced more pain both at the start and at the end of the treatment than patients with chest pain [median 8 (interquartile ranges (IQR 6-9)) vs. 6 (IQR 4-7) and 4 (IQR 2-6) vs. 2 (IQR 0-4), P<0.001], but were treated with similar doses as in patients with chest pain [median 7.5 (IQR 5-10) and 5 (IQR 2.5-7.5), P=0.09]. Inadequate analgesia was frequently observed for both patient groups. The protocol was not fully utilized, suggesting that education in pharmacology and follow-up of the EMSP is required.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23242076     DOI: 10.1097/MEJ.0b013e32835c9fa3

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  9 in total

1.  [Analgesia for trauma patients in emergency medicine].

Authors:  D Häske; B W Böttiger; B Bouillon; M Fischer; Gernot Gaier; B Gliwitzky; M Helm; P Hilbert-Carius; B Hossfeld; B Schempf; A Wafaisade; M Bernhard
Journal:  Anaesthesist       Date:  2020-02       Impact factor: 1.041

Review 2.  Analgesia in Patients with Trauma in Emergency Medicine.

Authors:  David Häske; Bernd W Böttiger; Bertil Bouillon; Matthias Fischer; Gernot Gaier; Bernhard Gliwitzky; Matthias Helm; Peter Hilbert-Carius; Björn Hossfeld; Christoph Meisner; Benjamin Schempf; Arasch Wafaisade; Michael Bernhard
Journal:  Dtsch Arztebl Int       Date:  2017-11-17       Impact factor: 5.594

3.  Use of morphine sulphate by South African paramedics for prehospital pain management.

Authors:  Craig Vincent-Lambert; Joalda Marthiné de Kock
Journal:  Pain Res Manag       Date:  2015 May-Jun       Impact factor: 3.037

4.  Prehospital intravenous fentanyl administered by ambulance personnel: a cluster-randomised comparison of two treatment protocols.

Authors:  Kristian D Friesgaard; Hans Kirkegaard; Claus-Henrik Rasmussen; Matthias Giebner; Erika F Christensen; Lone Nikolajsen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2019-02-07       Impact factor: 2.953

5.  Pain is vital in resuscitation in trauma.

Authors:  Theodosios Saranteas; Andreas Kostroglou; Dimitrios Anagnostopoulos; Dimitrios Giannoulis; Pantelis Vasiliou; Andreas F Mavrogenis
Journal:  SICOT J       Date:  2019-08-15

6.  Role of Inhaled Methoxyflurane in the Management of Acute Trauma Pain.

Authors:  Andrea Fabbri; Germana Ruggiano; Sergio Garcia Collado; Agnes Ricard-Hibon; Umberto Restelli; Giovanni Sbrana; Franco Marinangeli; Alberto Farina; Frank Coffey
Journal:  J Pain Res       Date:  2020-06-25       Impact factor: 3.133

7.  Knowledge and Attitude of Saudi Emergency Medical Services Students Regarding Pain Management: A Cross-Sectional Study.

Authors:  Daifallah M AlRazeeni
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

8.  A description of pharmacological analgesia administration by public sector advanced life support paramedics in the City of Cape Town.

Authors:  Ryan Matthews; Michael McCaul; Wayne Smith
Journal:  Afr J Emerg Med       Date:  2017-01-28

9.  Differences in pain treatment between surgeons and anaesthesiologists in a physician staffed prehospital emergency medical service: a retrospective cohort analysis.

Authors:  Stefan J Schaller; Felix P Kappler; Claudia Hofberger; Jens Sattler; Richard Wagner; Gerhard Schneider; Manfred Blobner; Karl-Georg Kanz
Journal:  BMC Anesthesiol       Date:  2019-01-31       Impact factor: 2.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.